Clinical trials in Hodgkin lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

To find out how you can access one of these clinical trials or to contact us with a question, see our page 'How to be referred'.

For an explanation on the different phases of trials click here.

 

 

Trial Name

 

Description

 

Click for more information (external page)

 

ADCT-301

 

A phase 1 study testing a new drug, ADCT-301

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

Avelumab HL (Javelin)

 

Phase 1 study of the immunotherapy drug avelumab.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

MK-3475-204

 

Phase 3 study of of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin.

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

*Please note, we update this page fortnightly

With special thanks to the following:

;